维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Zent CS"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia显示文摘	Maddocks-Christianson K Slager SL Zent CS	2007	Br J Haemato12007，139，3：	1
2	Phase I Trial of DailyOral Polyphenon E in Patients With Asymptomatic Rai Stage0 to II Chronic Lymphocytic Leukemia显示文摘	Shanafelt TD Call TG Zent CS	2009	Clinical Oncology2009，27，23：	1
3	Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia 显示文摘	Shanafelt TD Call TG Zent CS	2009	J Clin Oncol2009，27，23：	1
4	Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia显示文摘	Palmer S Hanson CA Zent CS	2008	BrJ Haematol2008，141，5：	1
5	Anti-CD20 antibody therapy for B-cell lymphomas显示文摘	Taylor RP Liudorfer MA Zent CS	2012	N Engl J Med2012，367，9：	1
6	Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma:changes in clinical presentation and prognosis显示文摘	Zent CS Ding W Reinalda MS		0，，08：	1
7	The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma显示文摘	Zent CS Ding W Schwager SM		0，，05：	1
8	Management of autoimmune cytopenia complicating chronic lymphocytic leukemia显示文摘	Zent CS Shanafelt T		0，，06：	1
9	Autoimmune complications in chronic lymphocyt- ic leukaemia (CLL) 显示文摘	Zent CS Kay NE	2010	Best Pract Res Clin Haematol2010，23，1：	1
10	Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early intermediate stage chronic lymphocytic leukemia(CLL) treated with alemtuzumab and rituximab显示文摘	Zent CS Secreto CR Implant BR	2008	Leuk Res2008，32，12：	1
11	Phase I trial of daily oral polyphenon E in patients with asymptomatic rai stage 0 to II chronic lymphocytic leukemia 显示文摘	Shanafelt TD Call TG Zent CS	2009	J Clin Oncol2009，27，23：	1
12	Linezolid-induced pure red blood cell aplasia显示文摘	Monson T Schichman SA Zent CS	2001	CAin J Dis2001，35，3：	1
13	The role of alemtuzumab in the treatment of chronic lymphocytic leukemia 显示文摘	Zent CS	2008	Leuk Lymphoma2008，49，：	1
14	Phase I trial of daily oral Polyphenon E in patients with asymptom-atic Rai stage 0 to II chronic lymphocytic leukemia显示文摘	Shanafelt TD Call TG Zent CS		0，，23：	1
15	Linezolid-induced pure red blood cell aplasia显示文摘	Monson T Schichman SA Zent CS	2002	Clin Infect Dis2002，35，1：	1
16	Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia显示文摘	Maddocks-Christianson K Slager SL Zent CS	2007	Br J Haematol2007，139，3：	1
17	Linezolid-indueed pure red blood cell aplasia显示文摘	Monson T Sehichman SA Zent CS	2002	Clin Infect Dis2002，35，3：	1
18	Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance 显示文摘	Mraz M Zent CS Church AK	2011	Br J Haematol2011，155，1：	1
19	Autoimmune complications in chronic lympho- cytic leukaemia (CLL)显示文摘	Zent CS Kay NE	2010	Best Practice Res Clin Haematol2010，23，1：	1
20	Phase I clinical trim of CpG oligonucleotide 7909 ( PF-03512676 ) in patients with previously treated chronic lymphocytic leukemia 显示文摘	Zent CS Smith BJ Ballas ZK	2012	Leuk Lymphoma2012，53，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示